dddd
PublishedJuly 1, 2025

Don’t Get it Twisted: New Discretionary Denials Process Hurts American Inventors

Following March’s announcement of a new interim, bifurcated review process for America Invents Act (AIA) petitions, the USPTO Acting Director has given herself largely unchecked authority to discretionarily deny patent validity challenges prior to their consideration on the merits. In the months since, the process, hastily and probably illegally implemented, has been exploited by non-practicing entities (NPEs) and foreign interests in an attempt to block meritorious challenges. While supporters of these changes will cherry-pick cases to argue that the new process protects U.S. innovators, a comprehensive look at the evidence tells a very different story.  And with the Fourth of July almost here, it’s a good time to show exactly how this process hurts Americans.

On Patent Progress, we’ve already highlighted how Acting Director Coke Morgan Stewart used the new review process to de-institute a request by Motorola Solutions for review of a patent held by the NPE Stellar LLC and its shadowy funder, IP Litfin. Despite the PTAB’s determination that the patent, related to law enforcement body-cam technology, was likely at least partially invalid, Stewart de-instituted the review for discretionary reasons preventing the proper advancement of an AIA proceeding.

NPEs like Stellar LLC and their funders have long opposed open and accessible PTAB reviews, and the new process gives an unneeded boost to their efforts to monetize low-quality IP via lawsuits. Indeed, a Unified Patents report found that this year NPEs had their busiest first quarter in nearly a decade—up 47% from Q1 2024. It’s not surprising, then, that we’ve seen—and will continue to see—PTAB detractors hold up the rare instances where discretionary denials may appear to favor U.S. companies over foreign interests. PTAB opponents need to make a big deal of these examples when they pop up, because they certainly are not representative of most discretionary denials at large. 

One such case involves Efficient Power Conversion Corporation (EPC), a California-based microchip company, which used the new denials process to challenge a petition brought by Chinese competitor, Innoscience. EPC retained the services of former Director Andrei Iancu, the creator of Fintiv—the flawed discretionary denials framework upon which Acting Director Stewart is now expanding. As one expert put it, Iancu has been “cashing in on the chaos he helped create.”  (We covered it here at Patent Progress as well.)

An op-ed from Rep. Nathaniel Moran in The Hill this month called the PTAB’s decision to invalidate EPC’s patents a “direct assault on American innovation and the Trump administration’s efforts to crack down on Chinese intellectual property theft.” Moran, who also reintroduced the RESTORE Act in the House this month, used this one-off case to advocate for the PREVAIL Act, which would codify significant alterations to who can access the PTAB and when.

However, this case is the exception, not the rule.

An analysis from Unified Patents reveals that while most petitioners at the PTAB are U.S.-based patent holders, most patent owners defending challenges are foreign-based. Denying petitions on discretionary grounds, then, usually means denying American innovators a chance to invalidate a low-quality patent—one usually being used against them in litigation.

Although it’s too early to gather complete data on the discretionary denials being requested under the new process, an early analysis from IAM suggests that concerning trends are already unfolding. Using data from Docket Navigator, IAM found that 68 discretionary denial requests were filed between March 26th and April 22nd to block petitions from American companies like Tesla, Microsoft, and Amazon. And who made these requests? You guessed it. According to IAM, “several well-known patent licensing companies” have been utilizing the new discretionary denial process, including “Daedalus Prime, Intellectual Ventures, and WSOU Investments”—some of the most prolific NPEs in the industry. Daedalus has been called out for targeting auto manufacturers, while Intellectual Ventures was once dubbed “Patent Troll Public Enemy #1” by IP Watchdog.

As of June 16th, Acting Director Stewart has ruled on 18 of these requests—granting seven and denying eleven. Among the granted denial requests is Stewart’s startling June 6th ruling in iRhythm v. Welch Allyn, in which she denied institution based on the “settled expectations” of the patent owner while ignoring the settled expectations of petitioners that they’d be able to pursue their petitions. 

That new standard is “upsetting [attorneys’] understanding of how to navigate the Patent Trial and Appeal Board,” and is just one way in which the new process is upending years-long precedent and rewriting agency rules to the detriment of American businesses and innovators. (That’s one reason why CCIA has filed amicus briefs in favor of overturning this new standard.)

Particularly in light of the new “settled expectations” standard, NPEs will remain eager to exploit the bifurcated review process to preserve their infringement lawsuits and maintain leverage over legitimate innovators, all while avoiding careful scrutiny of their patents’ quality.

So don’t be fooled if NPEs and their defenders cherry-pick the rare cases where PTAB review denials appear to help actual American inventors. The reality is that when low-quality patents are able to avoid review for reasons that have nothing to do with the merits of each case, it will allow for manipulation by those who seek to abuse the IP system at the expense of businesses and inventors who are operating in good faith and trying to follow the rules. 

The growing body of evidence is far more powerful than any spin some advocates try to put on an individual case.

Josh Landau

Patent Counsel, CCIA

Joshua Landau is the Patent Counsel at the Computer & Communications Industry Association (CCIA), where he represents and advises the association regarding patent issues.  Mr. Landau joined CCIA from WilmerHale in 2017, where he represented clients in patent litigation, counseling, and prosecution, including trials in both district courts and before the PTAB.

Prior to his time at WilmerHale, Mr. Landau was a Legal Fellow on Senator Al Franken’s Judiciary staff, focusing on privacy and technology issues.  Mr. Landau received his J.D. from Georgetown University Law Center and his B.S.E.E. from the University of Michigan.  Before law school, he spent several years as an automotive engineer, during which time he co-invented technology leading to U.S. Patent No. 6,934,140.

Follow @PatentJosh on Twitter.

More Posts

Tuesday Markup of Litigation Funding Legislation

Although John Squires is busy destroying the PTAB—as of last week, he has now gone 0 for 34 on allowing institution of IPR petitions he reviews—the story in Congress is more positive. Tomorrow, t...

Step 1: Destroy IPR.  Step 2: ???  Step 3: Profit.

Last week, the USPTO issued a Notice of Proposed Rulemaking (NPRM) containing major changes to the institution process for inter partes review.  Combined with other changes made by the USPTO, inc...

Capable of Repetition, But Avoiding Review—USPTO New Regulation Not Reviewed By OIRA

The USPTO has put out a new NPRM, attempting to lock in place rules that were created without going through rulemaking in the prior Trump administration. While I have a lot to say about the substance...

Subscribe to Patent Progress

No spam. Unsubscribe anytime.